These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 797349)

  • 1. [Controlled clinical research on the potassium-retaining action of various diuretic drugs].
    Giordano MP; Allegri M
    Arch Sci Med (Torino); 1976; 133(3):271-6. PubMed ID: 797349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum trace-element levels in piretanide-treated hypertensives: a double-blind trial against hydrochlorothiazide plus amiloride.
    Verho M; Bossaller W; Heinen B
    Int J Clin Pharmacol Res; 1987; 7(1):5-11. PubMed ID: 3294616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potassium-sparing diuretics and hyperkalaemia--still a problem.
    Tormey WP; Jina AG; Stone C
    Ir Med J; 1989 Dec; 82(4):179. PubMed ID: 2621084
    [No Abstract]   [Full Text] [Related]  

  • 4. [Modern diuretic preparations. III. Potassium-saving diuretics].
    Glezer GA; Lipko DS
    Ter Arkh; 1992; 64(8):106-9. PubMed ID: 1440383
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of the potassium and magnesium-sparing properties of amiloride and spironolactone in diuretic-treated normal subjects.
    Murdoch DL; Forrest G; Davies DL; McInnes GT
    Br J Clin Pharmacol; 1993 Apr; 35(4):373-8. PubMed ID: 8485017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Potassium-sparing diuretics (spironolactone, triamterene, amylorid)].
    Haris A; Radó J
    Orv Hetil; 1996 Sep; 137(35):1907-14. PubMed ID: 8927344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure.
    Shah KB; Rao K; Sawyer R; Gottlieb SS
    J Am Coll Cardiol; 2005 Sep; 46(5):845-9. PubMed ID: 16139135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open, parallel group study comparing a frusemide/amiloride diuretic and a diuretic containing cyclopenthiazide with sustained release potassium in the treatment of congestive cardiac failure--a multicentre general practice study.
    Allman S; Norris RJ
    J Int Med Res; 1990; 18 Suppl 2():17B-23B. PubMed ID: 2193840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Amiloride. A clinical study of a potassium-retaining diuretic].
    Juul J
    Ugeskr Laeger; 1969 Oct; 131(42):1785-90. PubMed ID: 4914022
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical experience with spironolactone in pediatrics.
    Buck ML
    Ann Pharmacother; 2005 May; 39(5):823-8. PubMed ID: 15811903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart failure drug poses potassium problems. When using "the water pill" spironolactone, watch your potassium intake and check your levels.
    Harv Heart Lett; 2004 Dec; 15(4):3. PubMed ID: 15704264
    [No Abstract]   [Full Text] [Related]  

  • 12. Indomethacin- and Moduretic--induced hyperkalemia.
    Mor R; Pitlik S; Rosenfeld JB
    Isr J Med Sci; 1983 Jun; 19(6):535-7. PubMed ID: 6862860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure.
    Tamirisa KP; Aaronson KD; Koelling TM
    Am Heart J; 2004 Dec; 148(6):971-8. PubMed ID: 15632880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal failure with potassium-sparing diuretics.
    Lynn KL; Bailey RR; Swainson CP; Sainsbury R; Low WI
    N Z Med J; 1985 Aug; 98(784):629-33. PubMed ID: 3861973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic studies on patients with resistant heart failure treated by spironolactone.
    BAYLEY TA; FORBATH PG; WILSON JK; HIGGINS HP
    Can Med Assoc J; 1962 Dec; 87(24):1263-6. PubMed ID: 13967089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EFFECT OF AN ALDOSTERONE ANTAGONIST (SPIRONOLACTONE) ON PATIENTS WITH SEVERE CONGESTIVE HEART FAILURE.
    CARRUTHERS BM; LEDRAY RD; SERAGLIA M; MCINTOSH HW; WALSH GC
    Can Med Assoc J; 1963 Sep; 89(13):633-41. PubMed ID: 14077808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Spironolactone and potassium].
    Kjeldsen K
    Ugeskr Laeger; 2004 Nov; 166(48):4392; author reply 4392-3. PubMed ID: 15587639
    [No Abstract]   [Full Text] [Related]  

  • 19. [Electrolyte excretion following administration of various diuretics in healthy females].
    Matzkies F; Webs B
    Fortschr Med; 1984 Feb; 102(6):133-7. PubMed ID: 6706271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of cardiac edema with a new diuretic (combination of amiloride hydrochlorate and hydrochlorothiazide)].
    Warembourg H; Bertrand ME; Ginestet A
    Lille Med; 1974 Feb; 19(2):193-98. PubMed ID: 4603928
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.